THY1 and breast carcinoma: In order to assess the expression of CD90 in human breast cancer samples, we first used immunohistochemistry reactions in TMA slides, each containing ~300 fragments of tissues from a cohort of patients from the AC Camargo Cancer Hospital (São Paulo, Brazil) (S1 Table).